AIM ImmunoTech Inc.
AIM · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $26 | $25 | $16 | $45 |
| % Growth | 4% | 56.3% | -64.4% | – |
| Cost of Goods Sold | $122 | $10 | $10 | -$51 |
| Gross Profit | -$96 | $15 | $6 | $96 |
| % Margin | -369.2% | 60% | 37.5% | 213.3% |
| R&D Expenses | $607 | $1,174 | $1,080 | $1,664 |
| G&A Expenses | $1,798 | $1,487 | $2,545 | $4,229 |
| SG&A Expenses | $1,798 | $1,487 | $2,545 | $4,287 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $58 |
| Other Operating Expenses | -$136 | $0 | $0 | $0 |
| Operating Expenses | $2,269 | $2,661 | $3,625 | $5,951 |
| Operating Income | -$2,365 | -$2,646 | -$3,619 | -$5,855 |
| % Margin | -9,096.2% | -10,584% | -22,618.8% | -13,011.1% |
| Other Income/Exp. Net | -$919 | -$148 | -$86 | -$112 |
| Pre-Tax Income | -$3,284 | -$2,794 | -$3,705 | -$5,967 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,284 | -$2,794 | -$3,705 | -$5,967 |
| % Margin | -12,630.8% | -11,176% | -23,156.3% | -13,260% |
| EPS | -1,568.71 | -3.68 | -0.05 | -0.1 |
| % Growth | -42,528% | -7,260% | 50% | – |
| EPS Diluted | -1,568.71 | -3.68 | -0.05 | -0.1 |
| Weighted Avg Shares Out | 2 | 759 | 703 | 568 |
| Weighted Avg Shares Out Dil | 2 | 759 | 703 | 568 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,052 | $10 | $11 | $1,813 |
| Interest Expense | $148 | $149 | $124 | $132 |
| Depreciation & Amortization | $54 | $55 | $122 | $64 |
| EBITDA | -$3,082 | -$2,590 | -$3,459 | -$5,771 |
| % Margin | -11,853.8% | -10,360% | -21,618.8% | -12,824.4% |